Twin Disc, Incorporated reported Q3 fiscal 2026 results on May 6 just hours before this note was filed, and the print crystallises a tension that has been building for weeks: the industrial machinery maker is genuinely growing again, but profitability has not kept pace — and the executives who know the business best had been reducing exposure at materially higher prices all winter.
The headline numbers tell a split story. Sales hit $96.7 million, up 19% year-over-year and above the $94 million consensus estimate. That is the good news. EPS of $0.23 missed the $0.27 estimate, pulling the stock down from earlier optimism. After a 5.4% bounce on May 5 — the day ahead of the print — shares are still down more than 8% on the week, leaving the price at $15.84, a level not seen in some time. The April 29 earnings-date predecessor (when the announcement was formally set) saw the stock drop 4.3% in a single session, and the week's net decline frames exactly how much the miss matters relative to the revenue beat.
The operational picture inside the call is more nuanced. CEO John Batten cited gross margin of 28.1%, EBITDA of $9.4 million, and EBITDA margin expansion of roughly 480 basis points versus the prior year. The six-month backlog climbed sequentially to $179.5 million. Defense is the fastest-moving piece: defense backlog rose approximately 20% year-over-year, now represents about 15% of total backlog, and management outlined a forward pipeline of $50 million to $75 million. Finland facility expansion is underway to support NATO-related vehicle programs via Katsa Oy. For a $217 million market-cap company, that pipeline is material.
The most conspicuous pre-print signal, however, came from the insiders. CEO John Batten and CFO Jeffrey Knutson — both participants on today's call — ran a sustained selling programme through February and early March, disposing of shares repeatedly in the $18.00–$18.25 range. Combined insider net selling over the 90-day window to March 5 totalled roughly $1.68 million in value, or approximately 92,500 net shares. Those sales came when the stock was 14% above where it trades today. The significance rating on each transaction was modest (3 out of 10), suggesting these were likely scheduled or formulaic sales rather than panic exits — but the direction is notable given the current price level. Neither insider has filed fresh purchase activity since.
Short interest is too small to be the story here. Estimated SI is just 0.43% of the free float — less than half a percent — and the lending market reflects it: availability is loose, cost to borrow is a negligible 1.35%, and the ORTEX short score is a muted 27.9. SI has drifted roughly 3% higher over the past week and about 42% higher over the past month in share terms, but from such a low base that directional pressure in the borrow market is effectively absent. Options are even more directionally clear: the put/call ratio has dropped to 0.025, roughly one-third of its 20-day average of 0.064, and more than a full standard deviation below the mean on the z-score. Calls dominate the open interest heavily, which is consistent with investors positioning for a recovery rather than hedging against further decline.
Analyst coverage is thin and stale — the most recent action on record is a Buy initiation at a $12 target from Longbow Research in April 2025, over a year ago. The screening data shows a return potential of roughly 51% implied by the mean price target, which a data-consistency check flags as possibly referencing dated targets. Treat that figure with caution given the sparse coverage. The dividend score ranks in the 83rd percentile, reflecting the company's consistency as a payer, though the actual yield at current prices is just 1.1% — the quarterly dividend was $0.04, unchanged. The dividend commitment is symbolic rather than capital-significant.
What to watch next is whether the defense pipeline translates into recognised backlog growth through Q4, and whether the EPS miss is read by the thin analyst community as a structural margin problem or a timing artefact — management leaned hard into the "timing" framing on delayed Oil & Gas transmission shipments to China. The stock has now surrendered nearly 10% year-to-date on a print where revenue growth was real but earnings execution fell short, and with the CEO still holding 17% of shares outstanding, the relationship between backlog conversion and the share price is one he is following closely.
See the live data behind this article on ORTEX.
Open TWIN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
